WO2022259222 - PROCESS FOR PREPARING AN ERK INHIBITOR
National phase entry:
Publication Number
WO/2022/259222
Publication Date
15.12.2022
International Application No.
PCT/IB2022/055416
International Filing Date
10.06.2022
Title **
[English]
PROCESS FOR PREPARING AN ERK INHIBITOR
[French]
PROCÉDÉ DE PRÉPARATION D'UN INHIBITEUR D'ERK
Applicants **
OTSUKA PHARMACEUTICAL CO., LTD.
2-9 Kanda Tsukasa-Machi
Chiyoda-Ku, Tokyo 101-8535, JP
Inventors
BODHURI, Prabhudas
c/o Astex Pharmaceuticals, Inc.
4420 Rosewood Drive, Suite 200
Pleasanton, California 94588, US
KHATRI, Hem Raj
c/o Astex Pharmaceuticals, Inc.
4420 Rosewood Drive, Suite 200
Pleasanton, California 94588, US
SCOTT, Ian
c/o Astex Pharmaceuticals, Inc.
4420 Rosewood Drive, Suite 200
Pleasanton, California 94588, US
READER, Michael
c/o Astex Therapeutics Limited
436 Cambridge Science Park
Milton Road
Cambridge, Cambridgeshire CB4 0QA, GB
LATHBURY, David Charles
c/o Astex Therapeutics Limited
436 Cambridge Science Park
Milton Road
Cambridge, Cambridgeshire CB4 0QA, GB
DAVAR, Nipun
c/o Astex Pharmaceuticals, Inc.
4420 Rosewood Drive, Suite 200
Pleasanton, California 94588, US
JOHNSON, Matthew
c/o Astex Pharmaceuticals, Inc.
4420 Rosewood Drive, Suite 200
Pleasanton, California 94588, US
Priority Data
63/209,877
11.06.2021
US
63/273,326
29.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2867 | |
| EPO | Filing, Examination | 26285 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 24110 |
Total: 54464 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure relates generally to methods for the preparation of Compound (I).[French]
La présente divulgation concerne de manière générale des procédés de préparation du composé (I).